Key points On Jan. 20, 2025, the incoming United States administration froze all foreign assistance funds for 90 days, including the President’s Emergency Plan for AIDS Relief (PEPFAR) funding.[1][1] ...

A 68-year-old man presented to the gastroenterology clinic with recurrent melena over 3 months with a history of recurrent spontaneous epistaxis and a familial pattern of similar bleeding among his ...

Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...

A 57-year-old woman was admitted to hospital with a 2-month history of fever and rash that had begun on her right hand and spread across her body over the previous 10 days. She had palp–able purpura ...

Multiple sclerosis (MS) often begins in early adulthood, and symptoms may include fatigue, pain, and mood changes. These may not be outwardly visible but can be deeply disabling.[1][1] Clinicians ...

Most antihistamines are safe during pregnancy and breastfeeding Systematic reviews of observational studies show no association with adverse fetal or maternal outcomes with antihistamine use during ...

A 24-year-old man was brought by ambulance to a rural hospital after a motor vehicle collision. On physical examination, he was hemodynamically unstable with a blood pressure of 60/40 mm Hg and a ...

More than 85 000 (2.3 per 1000) people in Canada have cerebral palsy, a group of disorders resulting from a nonprogressive brain lesion early in life. Seventy-five percent of those living with ...

Young-onset type 2 diabetes is defined as type 2 diabetes diagnosed before age 40 years The annual incidence in Canada is 50–150 per 100 000 people aged 20–29 years and is rapidly rising. 1, 2 Type 2 ...

Delirium occurs in 30%–50% of adults aged 65 years or older admitted to hospital, and may be hypoactive (lethargy, reduced psychomotor functioning), hyperactive (agitation, hallucinations) or mixed.1 ...

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

Key points New evidence has led to a change in the way that some patients with amyotrophic lateral sclerosis (ALS) are classified and treated. Based on the findings of a landmark trial,[1][1] the drug ...